Viral and microbial proteins

Viral and microbial proteins represent a vast and diverse array of molecular entities encoded by pathogenic organisms such as viruses, bacteria, and fungi. These proteins are essential for the survival, replication, and virulence of the pathogens within a host environment, facilitating processes like genome replication, structural assembly, host cell attachment, and evasion of the host immune system (NCBI, 2023). In drug discovery, specific proteins within this category—such as viral polymerases, bacterial ribosomes, or fungal cell wall enzymes—serve as the primary targets for anti-infective therapies (Nature Reviews Drug Discovery, 2017). Targeting these proteins allows for selective toxicity, aiming to eliminate the pathogen while minimizing harm to the host's own cellular machinery. For example, viral proteases are targeted to treat HIV and HCV, while bacterial ribosomes are targeted by macrolides to inhibit protein synthesis (NIH, 2021). However, the term 'viral and microbial proteins' is a high-level classification for thousands of distinct targets rather than a single, well-defined therapeutic receptor or enzyme. Consequently, it is generally considered a category descriptor in pharmacological databases rather than a discrete target for drug development.

Other names

Pathogen proteinsMicrobial antigensViral antigensInfectious agent proteins

Inhibition of essential pathogen processes including nucleic acid synthesis, protein translation, cell wall assembly, and viral entry or egress.